Research suggests increasing synaptic activity could alleviate SMA symptoms: motor function of mice was improved when treated with a glutamate receptor stimulant.
Researchers have discovered a new mitochondrial mechanism behind Parkinson’s disease, which could have key implications for future treatment.
Lauren Pulling highlights some of the key trending topics in neurology and neuroscience from 2016, as well as the top read articles of the year – take a look and let us know your thoughts.
In this interview, Mark Frasier discusses a recent Editorial from the Michael J. Fox Foundation and looks ahead to the future of precision medicine for Parkinson’s disease.
Endoplasmic reticulum stress revealed as potential cause for neurodegeneration in fruit fly model of Parkinson’s disease.
A new Mayo Clinic study has identified a potential link between smoking cessation and increase in Parkinson’s disease incidence.
Researchers have uncovered the neurotoxic mechanism of alpha-synuclein present in Parkinson’s disease.
Researchers demonstrate that amyotrophic lateral sclerosis (ALS) neuronal degeneration may be reduced following treatment with a growth factor, IGF-2, indicating a possible new target for ALS treatment.
Newly presented findings from a Phase III study of the investigational glucocorticoid, termed deflazacort, for the treatment of Duchenne Muscular Dystrophy show promise at the American Academy of Neurology 68th Annual Meeting.